Supplying life: Supply chain in life sciences has been saved
Supplying life: Supply chain in life sciences
A 2015 benchmarking survey
Keeping up-to-date on industry trends – and responses – is crucial to remaining on top, particularly in the complex and changing world of the pharmaceutical supply chain. This research shows the key role the supply chain plays in the industry in creating competitive advantage, and provides insight from supply chain leaders across the sector.
Executive summary / key findings
Globally the life sciences sector is operating in a period of significant transformation, and our experience shows us that the Irish pharmaceutical supply market mirrors that global environment. Increased pressure by governments to reduce costs, an ageing population, and an increase in chronic disease, are key influencers. Although challenges to some, these influencing factors present opportunities for companies agile enough to satisfy the required increased demand for health-related goods and services.
With Ireland positioned among the global leaders in the life science industry, this 2015 benchmarking survey provides necessary global insight for Irish leaders. The survey answers some of the global pharmaceutical industry’s most pressing questions related to sector preparedness, challenges and technology advancements. Key findings include:
- A strong desire for integrated end-to-end supply chain planning: 96% of respondents want integrated end-to-end supply chain planning – but only 20% have it fully implemented.
- Willingness to collaborate: Over 55% of those surveyed think it’s important to work with other pharmaceutical companies to develop a more effective supply chain. Only 4% of respondents were strongly against collaboration.
- Opportunities in Asia-Pacific: Over 40% of respondents think the Asia-Pacific region provides supply chain with the greatest opportunity to influence the market access capability of their companies
- Work in progress: Nearly 60% of respondents are still developing processes to ensure full compliance with the EU’s directive on global serialisation requirements.
Deloitte Ireland is committed to keeping our clients up-to-date on sector developments, inside and outside of the Irish market, and bringing you the best insights from the Deloitte network of global firms. This report was produced by LogiPharma in conjunction with Deloitte UK, and presents a global view of supply chain trends.